[PHARMA] QoQ Quarter Result on 30-Jun-2012 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
08-Aug-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
30-Jun-2012 [#2]
Profit Trend
QoQ- -45.22%
YoY- 12.88%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Revenue 500,339 482,404 426,460 456,737 446,745 367,786 371,432 21.94%
PBT 36,924 4,248 28,493 27,618 42,955 16,368 15,646 77.16%
Tax -11,771 -11,716 -2,957 -11,541 -13,894 -4,186 -4,687 84.65%
NP 25,153 -7,468 25,536 16,077 29,061 12,182 10,959 73.91%
-
NP to SH 24,771 -7,934 25,247 15,713 28,685 11,942 10,811 73.71%
-
Tax Rate 31.88% 275.80% 10.38% 41.79% 32.35% 25.57% 29.96% -
Total Cost 475,186 489,872 400,924 440,660 417,684 355,604 360,473 20.20%
-
Net Worth 484,829 472,037 496,469 481,394 474,161 514,153 464,092 2.95%
Dividend
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Div 8,825 11,771 11,764 8,827 8,824 35,296 - -
Div Payout % 35.63% 0.00% 46.60% 56.18% 30.76% 295.57% - -
Equity
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Net Worth 484,829 472,037 496,469 481,394 474,161 514,153 464,092 2.95%
NOSH 117,676 117,715 117,646 117,700 117,657 117,655 106,933 6.58%
Ratio Analysis
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
NP Margin 5.03% -1.55% 5.99% 3.52% 6.51% 3.31% 2.95% -
ROE 5.11% -1.68% 5.09% 3.26% 6.05% 2.32% 2.33% -
Per Share
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
RPS 425.18 409.81 362.49 388.05 379.70 312.60 347.35 14.41%
EPS 21.05 -6.74 21.46 13.35 24.38 10.15 10.11 62.98%
DPS 7.50 10.00 10.00 7.50 7.50 30.00 0.00 -
NAPS 4.12 4.01 4.22 4.09 4.03 4.37 4.34 -3.40%
Adjusted Per Share Value based on latest NOSH - 117,700
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
RPS 34.72 33.47 29.59 31.69 31.00 25.52 25.77 21.96%
EPS 1.72 -0.55 1.75 1.09 1.99 0.83 0.75 73.81%
DPS 0.61 0.82 0.82 0.61 0.61 2.45 0.00 -
NAPS 0.3364 0.3275 0.3445 0.334 0.329 0.3567 0.322 2.95%
Price Multiplier on Financial Quarter End Date
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Date 29/03/13 31/12/12 28/09/12 29/06/12 30/03/12 30/12/11 30/09/11 -
Price 8.26 8.10 7.55 10.18 5.90 5.36 5.90 -
P/RPS 1.94 1.98 2.08 2.62 1.55 1.71 1.70 9.19%
P/EPS 39.24 -120.18 35.18 76.25 24.20 52.81 58.36 -23.23%
EY 2.55 -0.83 2.84 1.31 4.13 1.89 1.71 30.49%
DY 0.91 1.23 1.32 0.74 1.27 5.60 0.00 -
P/NAPS 2.00 2.02 1.79 2.49 1.46 1.23 1.36 29.28%
Price Multiplier on Announcement Date
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Date 15/05/13 18/02/13 06/11/12 08/08/12 03/05/12 22/02/12 01/11/11 -
Price 9.26 7.80 8.25 8.83 5.90 5.90 5.90 -
P/RPS 2.18 1.90 2.28 2.28 1.55 1.89 1.70 18.01%
P/EPS 43.99 -115.73 38.44 66.14 24.20 58.13 58.36 -17.16%
EY 2.27 -0.86 2.60 1.51 4.13 1.72 1.71 20.76%
DY 0.81 1.28 1.21 0.85 1.27 5.08 0.00 -
P/NAPS 2.25 1.95 1.95 2.16 1.46 1.35 1.36 39.83%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment